ImmuCell Corporation

About ImmuCell Corporation

ImmuCell is an entrepreneurial animal health company focused on developing, manufacturing, and marketing scientifically-proven products to maximize the genetic potential of dairy and beef cattle through disease prevention and reduced dependence on antibiotics. Their mission is to make life easier and business more profitable for dairy and beef producers by adhering to high standards and maintaining a lean operation.

Products & Services

First Defense®:A USDA-accredited, colostrum-derived scours preventative providing Immediate Immunity™ against E. coli, coronavirus, and rotavirus, the main causes of neonatal scours in newborn calves.

Re-Tain®:An intramammary treatment for subclinical mastitis nearing FDA approval. Unlike traditional antibiotics, it requires no milk discard or meat withhold, allowing economically justified treatment before clinical signs appear.

CMT for Mastitis:A product related to mastitis testing or treatment, specific details not provided in the content.

Specialties

Disease prevention in dairy and beef cattle Colostrum antibody concentration and purification Mastitis treatment innovation Reduction of antibiotic use in food chain

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 3000000 MR: - FA: $3 million FAN: 3000000	D: 2023-06-15 FD: 2023-06-15	2 investors

Debt Latest

2023-06-15

$3.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael F. Brigham

President and Chief Executive Officer, Director

T

Timothy C. Fiori

Chief Financial Officer

B

Bobbi Jo Brockmann

Vice President of Sales and Marketing, Director

G

Gloria J. Basse

Director

B

Bryan Gathagan

Director

S

Steven T. Rosgen

Director

View 5 more team members with Pro

Unlock Full Team Directory

Recent News